Cargando…

A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity

BACKGROUND: Vaccines are the most effective means to fight and eradicate infectious diseases. Live-attenuated vaccines (LAV) usually have the advantages of single dose, rapid onset of immunity, and durable protection. DNA vaccines have the advantages of chemical stability, ease of production, and no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Jing, Xie, Xuping, Luo, Huanle, Shan, Chao, Muruato, Antonio E., Weaver, Scott C., Wang, Tian, Shi, Pei-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197676/ https://www.ncbi.nlm.nih.gov/pubmed/30201444 http://dx.doi.org/10.1016/j.ebiom.2018.08.056

Ejemplares similares

Maternal vaccination and protective immunity against Zika virus vertical transmission
por: Shan, Chao, et al.
Publicado: (2019)

A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine
por: Yang, Yujiao, et al.
Publicado: (2017)

A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage
por: Shan, Chao, et al.
Publicado: (2017)

An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction
por: Xia, Hongjie, et al.
Publicado: (2018)

Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis
por: Xie, Xuping, et al.
Publicado: (2017)

Peli1 signaling blockade attenuates congenital zika syndrome
por: Luo, Huanle, et al.
Publicado: (2020)

Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
por: Chen, Qi, et al.
Publicado: (2018)

Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine
por: Sharma, Sapna, et al.
Publicado: (2020)

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
por: Liu, Yang, et al.
Publicado: (2022)

A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission
por: Adam, Awadalkareem, et al.
Publicado: (2021)

Zika Virus Replicons for Drug Discovery
por: Xie, Xuping, et al.
Publicado: (2016)

A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
por: Liu, Yang, et al.
Publicado: (2022)

Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
por: Liu, Yang, et al.
Publicado: (2022)

Genetic and biochemical characterizations of Zika virus NS2A protein
por: Zhang, Xianwen, et al.
Publicado: (2019)

Erratum for Chen et al., “Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate”
por: Chen, Qi, et al.
Publicado: (2019)

A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity
por: Adam, Awadalkareem, et al.
Publicado: (2023)

A single-dose live attenuated chimeric vaccine candidate against Zika virus
por: Chin, Wei-Xin, et al.
Publicado: (2021)

Rational Development of Live-Attenuated Zika Virus Vaccines
por: Adam, Awadalkareem, et al.
Publicado: (2023)

Repurposing an HIV Drug for Zika Virus Therapy
por: Xie, Xuping, et al.
Publicado: (2019)

Role of microglia in the dissemination of Zika virus from mother to fetal brain
por: Xu, Pei, et al.
Publicado: (2020)

Correction: Role of microglia in the dissemination of Zika virus from mother to fetal brain
por: Xu, Pei, et al.
Publicado: (2021)

Using Next Generation Sequencing to Study the Genetic Diversity of Candidate Live Attenuated Zika Vaccines
por: Collins, Natalie D., et al.
Publicado: (2020)

An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses
por: Li, Guangyu, et al.
Publicado: (2019)

Inhibition of innate immune response ameliorates Zika virus-induced neurogenesis deficit in human neural stem cells
por: Xu, Pei, et al.
Publicado: (2021)

Using recombination-dependent lethal mutations to stabilize reporter flaviviruses for rapid serodiagnosis and drug discovery
por: Baker, Coleman, et al.
Publicado: (2020)

Identifying optimal capsid duplication length for the stability of reporter flaviviruses
por: Baker, Coleman, et al.
Publicado: (2020)

A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis
por: Wong, Susan J., et al.
Publicado: (2017)

Zika Virus NS2A-Mediated Virion Assembly
por: Zhang, Xianwen, et al.
Publicado: (2019)

Characterization of a Novel Murine Model to Study Zika Virus
por: Rossi, Shannan L., et al.
Publicado: (2016)

Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine
por: Giel-Moloney, Maryann, et al.
Publicado: (2018)

Zika structural genes determine the virulence of African and Asian lineages
por: Nunes, Bruno T. D., et al.
Publicado: (2020)

A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients
por: Shan, Chao, et al.
Publicado: (2017)

The Soyuz launch vehicle: the two lives of an engineering triumph
por: Lardier, Christian, et al.
Publicado: (2013)

Emergence of Epidemic Zika Virus Transmission and Congenital Zika Syndrome: Are Recently Evolved Traits to Blame?
por: Weaver, Scott C.
Publicado: (2017)

Launched
Publicado: (1885)

Fragile X mental retardation protein is a Zika virus restriction factor that is antagonized by subgenomic flaviviral RNA
por: Soto-Acosta, Ruben, et al.
Publicado: (2018)

A systematic approach to the development of a safe live attenuated Zika vaccine
por: Kwek, Swee Sen, et al.
Publicado: (2018)

AMS - LAUNCH
por: Vanden Broeck, Renilde
Publicado: (2019)

Preparing for the Launch...
Publicado: (1979)

The Launch of Sarcoma
por: Robinson, Martin
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_drtcf8etkfl4hrfit10u1oal30